Financials

  • Market Capitalization 8.1 B
  • Employee 691
  • Founded 2014
  • CEO Rich Adcock
  • Website www.immunitybio.com
  • Headquarter Delaware, United States
  • FIGI BBG007T9DYW9
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-9.02
Fiyat/satışlar oranı
51.72

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
1030
PCVX
Vaxcyte, Inc. - Common Stock
56.73 USD+0.93%-3.37%+14.44%+34.11%8.19 B USD
1032
IMVT
Immunovant, Inc. - Common Stock
39.89 USD+2.89%-1.04%+20.11%+107.65%8.19 B USD
1057
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
61.69 USD-0.47%-4.74%+18.18%+55.61%7.71 B USD
1077
RYTM
Rhythm Pharmaceuticals, Inc. - Common Stock
109.62 USD-0.31%-4.09%+20.54%-0.63%7.51 B USD

Haberler